Evidence map›Paper›PMID 32854353›Full record

ArticleBiomolecules2020

Functional Analysis of P450 Monooxygenase SrrO in the Biosynthesis of Butenolide-Type Signaling Molecules in

Aiko Teshima, Nozomi Hadae, Naoto Tsuda, Kenji Arakawa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aiko TeshimaDepartment of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan.
Nozomi HadaeDepartment of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan.
Naoto TsudaDepartment of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan.
Kenji ArakawaDepartment of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan.ORCID 0000-0001-5129-0042
Hiroshima University · JP

Funding

Japan Society for the Promotion of Science 16H04917 and 16K14915Ministry of Education, Culture, Sports, Science and Technology 23108515, 25108718, 17H05446 and 19H04659
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

4-ButyrolactoneAnti-Bacterial AgentsBacterial ProteinsBiosynthetic PathwaysChromatography, High Pressure LiquidCytochrome P-450 Enzyme SystemErythromycinGenes, BacterialMacrolidesMagnetic Resonance SpectroscopyMolecular StructureMutationSignal TransductionSpectrometry, Mass, Electrospray IonizationStreptomyces4-ButyrolactoneAnti-Bacterial AgentsBacterial ProteinsbutenolideCytochrome P-450 Enzyme SystemErythromycinkujimycin BlankacidinsMacrolidesbiosynthesiscytochrome P450secondary metabolitesignaling moleculeStreptomyces

Identifiers

PMID32854353
PMCPMC7564063
OpenAlexW3081361694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.